Company Overview - Arcus Biosciences was founded approximately 10 years ago with a focus on developing a strong small molecule group and exceptional medicinal chemistry capabilities [2] - The company currently has two late-stage oncology programs and is developing an emerging immunology portfolio [2] Clinical Trials and Strategy - Arcus has a history of conducting numerous clinical trials, including large late-stage clinical trials, while also maintaining an aggressive discovery research group, which is considered somewhat unusual in the industry [3] - The company has successfully leveraged partnerships to support its strategy, resulting in strong capitalization with $1 billion in available funds [3]